Regulatory Strength Eigen holds ISO 13485 certification and emphasizes rigorous risk management, regulatory compliance, and safe medical device design, which can facilitate market entry and sales negotiations across Canada, EU, Latin America, Middle East, Asia, and the USA.

Imaging Focus Strategic positioning around image-guided diagnosis and treatment for prostate cancer suggests opportunities with radiology and urology departments, as well as oncology centers seeking advanced localization and management tools.

IP & Innovation A growing patent portfolio signals defensible technology and potential for upsell or cross-sell of novel imaging breakthroughs to large hospitals and specialized cancer centers seeking cutting-edge solutions.

Mid-Market Scale With 1000+ employees and revenue in the tens of millions, Eigen sits in a scale where there is room to deploy pilots in regional health systems, then scale to multisite hospital networks and distributors.

Global Outreach Existing international reach and regulatory alignment create opportunities for global partnerships, distributors, and co-development deals, especially in markets targeting oncology imaging and minimally invasive therapies.